Literature DB >> 10788459

Mutational analysis of the substrate binding/catalytic domains of human M form and P form phenol sulfotransferases.

M C Liu1, M Suiko, Y Sakakibara.   

Abstract

Human monoamine (M) form and simple phenol (P) form phenol sulfotransferases (PSTs) are greater than 93% identical in their primary sequences and yet display distinct substrate specificities and other enzymatic properties. Through the generation and characterization of a series of chimeric PSTs, we have previously demonstrated two highly variable regions within their sequences to be responsible for determining their substrate phenotypes (Sakakibara, Y., Takami, Y., Nakayama, T., Suiko, M., and Liu, M.-C. (1998) J. Biol. Chem. 273, 6242-6247). By employing the site-directed mutagenesis technique, the present study aims to identify and quantitatively evaluate the specific amino acid residues critical to the substrate binding and catalysis in these two enzymes. Twelve mutated M-PSTs and seven mutated P-PSTs were generated, expressed, and purified. Enzymatic characterization showed that, of the twelve mutated M-PSTs, mutations at residues Asp-86, Glu-89, and Glu-146 resulted in a dramatic decrease in V(max)/K(m) with dopamine as substrate, being greater than 450 times for the D86A/E89I/E146A mutated M-PST. With p-nitrophenol as substrate, the V(max)/K(m) determined for the D86A/E89I/E146A-mutated M-PST increased more than 25 times and approached that determined for the wild-type P-PST. These results indicated that the concerted action of the three mutated residues (D86A, E89I, and E146A) is sufficient for the conversion of the substrate phenotype of M-PST to that of P-PST. Among the mutated P-PSTs, the I89E- and A146E-mutated P-PSTs displayed considerable deviations in V(max)/K(m) with dopamine or p-nitrophenol as substrate. No corresponding changes, however, were detected with the opposite compound as substrate. These results indicated that, in contrast to M-PST, mutations at Ala-86, Ile-89, and Ala-146 to the corresponding residues in M-PST are not sufficient for rendering the change of P-PST substrate phenotype to that of M-PST. For both M-PSTs and P-PSTs, mutations at Lys-48 or His-108 led to the loss of sulfotransferase activities, indicating their importance in the catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788459     DOI: 10.1074/jbc.275.18.13460

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis.

Authors:  Akihiro Yamamoto; Ming-Yih Liu; Katsuhisa Kurogi; Yoichi Sakakibara; Yuichi Saeki; Masahito Suiko; Ming-Cheh Liu
Journal:  J Biochem       Date:  2015-06-11       Impact factor: 3.387

2.  Secretory expression of the rat aryl sulfotransferases IV with improved catalytic efficiency by molecular engineering.

Authors:  Zhengxiong Zhou; Qing Li; Ruirui Xu; Bingbing Wang; Guocheng Du; Zhen Kang
Journal:  3 Biotech       Date:  2019-06-03       Impact factor: 2.406

3.  Detoxication of benzo[a]pyrene-7,8-dione by sulfotransferases (SULTs) in human lung cells.

Authors:  Li Zhang; Meng Huang; Ian A Blair; Trevor M Penning
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

4.  SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies.

Authors:  Shengnan Meng; Baojian Wu; Rashim Singh; Taijun Yin; John Kenneth Morrow; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

5.  Arginine residues in the active site of human phenol sulfotransferase (SULT1A1).

Authors:  Guangping Chen; Xinrong Chen
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

6.  Amino acid residue 247 in canine sulphotransferase SULT1D1: a new determinant of substrate selectivity.

Authors:  Carrie Tsoi; Mikael Widersten; Ralf Morgenstern; Stellan Swedmark
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

7.  Effects of genetic polymorphisms on the sulfation of doxorubicin by human SULT1C4 allozymes.

Authors:  Saud A Gohal; Mohammed I Rasool; Ahsan F Bairam; Eid S Alatwi; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  J Biochem       Date:  2021-10-12       Impact factor: 3.387

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.